LIVE

Serial Number

86399751

Owner

Vertex Pharmaceuticals Incorporated

Attorney

Lisa Tittemore

First Use Date

Jul 8, 2015

Filing Date

Sep 19, 2014

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ORKAMBI Trademark

Serial Number: 86399751 • Registration: 4828608

ORKAMBI is a trademark filed by Vertex Pharmaceuticals Incorporated on September 19, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Vertex Pharmaceuticals Incorporated (3 trademarks)

50 Northern Avenue
Boston, MA 02210

Entity Type: 03

Legal Representation

Attorney of Record

Lisa Tittemore

108 trademarks filed View all →

Correspondence Address

Lisa Tittemore Merchant & Gould P.C.

P.O. Box 2910

Minneapolis, MN 55402-0910

United States

Trademark Details

Filing Date

September 19, 2014

Registration Date

October 6, 2015

First Use Anywhere

July 8, 2015

First Use in Commerce

July 8, 2015

Published for Opposition

March 24, 2015

Goods & Services

Pharmaceutical preparations for the treatment of cystic fibrosis

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 2, 2026 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 2, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 2, 2026 REAP

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Dec 13, 2025 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Dec 13, 2025 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Dec 13, 2025 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 13, 2025 APRE

TEAS SECTION 8 & 9 RECEIVED

Sep 5, 2025 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 6, 2024 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Nov 20, 2021 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Nov 20, 2021 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 20, 2021 APRE

TEAS SECTION 8 & 15 RECEIVED

Aug 19, 2021 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 6, 2020 REM1

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 10, 2020 TCCA

REGISTERED-PRINCIPAL REGISTER

Oct 6, 2015 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 29, 2015 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 28, 2015 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Aug 17, 2015 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 17, 2015 AITU

USE AMENDMENT FILED

Aug 3, 2015 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 3, 2015 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 19, 2015 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 24, 2015 NPUB

PUBLISHED FOR OPPOSITION

Mar 24, 2015 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 4, 2015 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 14, 2015 PREV

ASSIGNED TO LIE

Feb 13, 2015 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 27, 2015 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 27, 2015 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 26, 2015 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 26, 2015 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 13, 2015 GNRN

NON-FINAL ACTION E-MAILED

Jan 13, 2015 GNRT

NON-FINAL ACTION WRITTEN

Jan 13, 2015 CNRT

ASSIGNED TO EXAMINER

Jan 6, 2015 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 27, 2014 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 26, 2014 NWOS

NEW APPLICATION ENTERED

Sep 23, 2014 NWAP

Related Trademarks

More from this Owner

POVTENZI

Serial #99518157

More in Same Class

420 PHARM

FIGHTING CANCER EVERY STEP OF THE WAY